Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Access offsets poverty in quest for CAR T cells

Rayne H. Rouce, Eneida Nemecek

Blood (2023) 141 (6): 558–560.

https://doi.org/10.1182/blood.2022018552

Published: 2023

Journal Articles

131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission

John M. Pagel, Frederick R. Appelbaum, Janet F. Eary, Joseph Rajendran, Darrell R. Fisher, Ted Gooley, Katherine Ruffner, Eneida Nemecek, Eileen Sickle, Larry Durack, Jeanette Carreras, Mary M. Horowitz, Oliver W. Press, Ajay K. Gopal, Paul J. Martin, Irwin D. Bernstein, Dana C. Matthews

Blood (2006) 107 (5): 2184–2191.

https://doi.org/10.1182/blood-2005-06-2317

Published: 2006

Journal Articles

A Prospective Study of G-CSF Primed Bone Marrow from Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study.

Haydar Frangoul, MD, Ann Woolfrey, MD, Shakila Khan, MD, Michael Pulsipher, MD, John Levine, MD, David Baker, MD, Mark Walters, MD, Mouhab Ayas, MD, Yaddanapudi Ravindranath, MD, Stephan Grupp, MD, PhD, Dean Billheimer, PhD, Eneida Nemecek, MD

Blood (2005) 106 (11): 1964.

https://doi.org/10.1182/blood.V106.11.1964.1964

Published: 2005

Journal Articles

131 I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Joseph G. Rajendran, MD, Ted Gooley, PhD, Darrell R. Fisher, PhD, Eneida Nemecek, MD, Ajay K. Gopal, MD, Michael B. Maris, MD, Katherine Ruffner, MD, Dana C. Matthews, MD, H. Joachim Deeg, MD, David G. Maloney, MD, PhD, Paul J. Martin, MD, Rainer Storb, MD

Blood (2005) 106 (11): 397.

https://doi.org/10.1182/blood.V106.11.397.397

Published: 2005

Journal Articles

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Janet F. Eary, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Ted Gooley, PhD, Eneida Nemecek, MD, Katherine Ruffner, MD, Eileen Sickle, RN, Larry Durack, CNMT, Jeanette Carreras, MPH, Mary M. Horowitz, MD, MS, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD, Paul J. Martin, MD, Irwin D. Bernstein, MD, Dana C. Matthews, MD

Blood (2004) 104 (11): 813.

https://doi.org/10.1182/blood.V104.11.813.813

Published: 2004

NARROW

Access offsets poverty in quest for CAR T cells

131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission

A Prospective Study of G-CSF Primed Bone Marrow from Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study.

131 I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

Email alerts

ASH Publications

American Society of Hematology

Access offsets poverty in quest for CAR T cells

131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission

A Prospective Study of G-CSF Primed Bone Marrow from Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study.

131 I-Anti-CD45 Antibody Plus Fludarabine, Low-Dose Total Body Irradiation and Peripheral Blood Stem Cell Infusion for Elderly Patients with Advanced Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS).

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only